NCT06479356 2024-08-21CD19-targeted CAR T Cells for Relapsed or Refractory (R/R) Large B-cell LymphomaShanghai Ming Ju Biotechnology Co., Ltd.Phase 2 Recruiting12 enrolled
NCT05370547 2024-03-06Chidamide Bridging for CAR-T TherapyChinese PLA General HospitalPhase 1/2 Recruiting120 enrolled
NCT03355859 2019-07-12Study Evaluating the Safety and Efficacy of JWCAR029 in Adult Subjects With Relapsed and Refractory B-cell Non-Hodgkin LymphomaRuijin HospitalPhase 1 Unknown10 enrolled